Current Hypertension Reports

, Volume 6, Issue 6, pp 477–484

Pheochromocytoma: Diagnosis and management update

  • William M. Manger
  • Graeme Eisenhofer
Article

DOI: 10.1007/s11906-004-0044-2

Cite this article as:
Manger, W.M. & Eisenhofer, G. Current Science Inc (2004) 6: 477. doi:10.1007/s11906-004-0044-2

Abstract

Pheochromocytoma is a rare but extremely treacherous neuroendocrine tumor causing manifestations by secreting catecholamines into the circulation. It is usually fatal if unrecognized. Manifestations can mimic many diseases and cause erroneous diagnoses. Approximately 15% are malignant, 18% extra-adrenal, and 20% familial. Plasma or urinary metanephrines are approximately 98% sensitive for detecting pheochromocytomas. They can be localized by MRI and CT; 131I- and 123I-metaiodobenzylguanidine (MIBG) are highly specific and 81% to 90% sensitive, respectively. Suspect pheochromocytoma in patients with sustained or paroxysmal hypertension or in normotensives having manifestations of hypercatecholaminemia. Surgical removal is usually curative; chemotherapy and radiotherapy are palliative for malignant pheochromocytomas.

Copyright information

© Current Science Inc. 2004

Authors and Affiliations

  • William M. Manger
    • 1
  • Graeme Eisenhofer
    • 1
  1. 1.New York University Medical Center and National Hypertension AssociationNew YorkUSA